• Je něco špatně v tomto záznamu ?

Hypothermic oxygenated machine perfusion (HOPE) for orthotopic liver transplantation of human liver allografts from extended criteria donors (ECD) in donation after brain death (DBD): a prospective multicentre randomised controlled trial (HOPE ECD-DBD)

Z. Czigany, W. Schöning, TF. Ulmer, J. Bednarsch, I. Amygdalos, T. Cramer, X. Rogiers, I. Popescu, F. Botea, J. Froněk, D. Kroy, A. Koch, F. Tacke, C. Trautwein, RH. Tolba, M. Hein, GH. Koek, CHC. Dejong, UP. Neumann, G. Lurje,

. 2017 ; 7 (10) : e017558. [pub] 20171010

Jazyk angličtina Země Anglie, Velká Británie

Typ dokumentu klinické zkoušky, fáze II, časopisecké články, multicentrická studie, randomizované kontrolované studie

Perzistentní odkaz   https://www.medvik.cz/link/bmc18024581

INTRODUCTION: Orthotopic liver transplantation (OLT) has emerged as the mainstay of treatment for end-stage liver disease. In an attempt to improve the availability of donor allografts and reduce waiting list mortality, graft acceptance criteria were extended increasingly over the decades. The use of extended criteria donor (ECD) allografts is associated with a higher incidence of primary graft non-function and/or delayed graft function. As such, several strategies have been developed aiming at reconditioning poor quality ECD liver allografts. Hypothermic oxygenated machine perfusion (HOPE) has been successfully tested in preclinical experiments and in few clinical series of donation after cardiac death OLT. METHODS AND ANALYSIS: HOPE ECD-DBD is an investigator-initiated, open-label, phase-II, prospective multicentre randomised controlled trial on the effects of HOPE on ECD allografts in donation after brain death (DBD) OLT. Human whole organ liver grafts will be submitted to 1-2 hours of HOPE (n=23) via the portal vein before implantation and are going to be compared with a control group (n=23) of patients transplanted after conventional cold storage. Primary (peak and Δ peak alanine aminotransferase within 7 days) and secondary (aspartate aminotransferase, bilirubin and international normalised ratio, postoperative complications, early allograft dysfunction, duration of hospital and intensive care unit stay, 1-year patient and graft survival) endpoints will be analysed within a 12-month follow-up. Extent of ischaemia-reperfusion (I/R) injury will be assessed using liver tissue, perfusate, bile and serum samples taken during the perioperative phase of OLT. ETHICS AND DISSEMINATION: The study was approved by the institutional review board of the RWTH Aachen University, Aachen, Germany (EK 049/17). The current paper represent the pre-results phase. First results are expected in 2018. TRIAL REGISTRATION NUMBER: NCT03124641.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc18024581
003      
CZ-PrNML
005      
20220407135456.0
007      
ta
008      
180709s2017 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1136/bmjopen-2017-017558 $2 doi
035    __
$a (PubMed)29018070
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Czigany, Zoltan $u Department of Surgery and Transplantation, University Hospital RWTH Aachen, Aachen, Germany.
245    10
$a Hypothermic oxygenated machine perfusion (HOPE) for orthotopic liver transplantation of human liver allografts from extended criteria donors (ECD) in donation after brain death (DBD): a prospective multicentre randomised controlled trial (HOPE ECD-DBD) / $c Z. Czigany, W. Schöning, TF. Ulmer, J. Bednarsch, I. Amygdalos, T. Cramer, X. Rogiers, I. Popescu, F. Botea, J. Froněk, D. Kroy, A. Koch, F. Tacke, C. Trautwein, RH. Tolba, M. Hein, GH. Koek, CHC. Dejong, UP. Neumann, G. Lurje,
520    9_
$a INTRODUCTION: Orthotopic liver transplantation (OLT) has emerged as the mainstay of treatment for end-stage liver disease. In an attempt to improve the availability of donor allografts and reduce waiting list mortality, graft acceptance criteria were extended increasingly over the decades. The use of extended criteria donor (ECD) allografts is associated with a higher incidence of primary graft non-function and/or delayed graft function. As such, several strategies have been developed aiming at reconditioning poor quality ECD liver allografts. Hypothermic oxygenated machine perfusion (HOPE) has been successfully tested in preclinical experiments and in few clinical series of donation after cardiac death OLT. METHODS AND ANALYSIS: HOPE ECD-DBD is an investigator-initiated, open-label, phase-II, prospective multicentre randomised controlled trial on the effects of HOPE on ECD allografts in donation after brain death (DBD) OLT. Human whole organ liver grafts will be submitted to 1-2 hours of HOPE (n=23) via the portal vein before implantation and are going to be compared with a control group (n=23) of patients transplanted after conventional cold storage. Primary (peak and Δ peak alanine aminotransferase within 7 days) and secondary (aspartate aminotransferase, bilirubin and international normalised ratio, postoperative complications, early allograft dysfunction, duration of hospital and intensive care unit stay, 1-year patient and graft survival) endpoints will be analysed within a 12-month follow-up. Extent of ischaemia-reperfusion (I/R) injury will be assessed using liver tissue, perfusate, bile and serum samples taken during the perioperative phase of OLT. ETHICS AND DISSEMINATION: The study was approved by the institutional review board of the RWTH Aachen University, Aachen, Germany (EK 049/17). The current paper represent the pre-results phase. First results are expected in 2018. TRIAL REGISTRATION NUMBER: NCT03124641.
650    _2
$a mladiství $7 D000293
650    _2
$a dospělí $7 D000328
650    _2
$a senioři $7 D000368
650    12
$a alografty $7 D064591
650    12
$a mozková smrt $7 D001926
650    _2
$a konečné stadium selhání jater $x chirurgie $7 D058625
650    _2
$a ženské pohlaví $7 D005260
650    12
$a přežívání štěpu $7 D006085
650    _2
$a lidé $7 D006801
650    12
$a játra $x patologie $x chirurgie $7 D008099
650    12
$a transplantace jater $7 D016031
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    12
$a kyslík $7 D010100
650    _2
$a perfuze $7 D010477
650    _2
$a prospektivní studie $7 D011446
650    12
$a dárci tkání $7 D014019
650    _2
$a získávání tkání a orgánů $7 D009927
650    _2
$a mladý dospělý $7 D055815
655    _2
$a klinické zkoušky, fáze II $7 D017427
655    _2
$a časopisecké články $7 D016428
655    _2
$a multicentrická studie $7 D016448
655    _2
$a randomizované kontrolované studie $7 D016449
700    1_
$a Schöning, Wenzel $u Department of Surgery and Transplantation, University Hospital RWTH Aachen, Aachen, Germany.
700    1_
$a Ulmer, Tom Florian $u Department of Surgery and Transplantation, University Hospital RWTH Aachen, Aachen, Germany.
700    1_
$a Bednarsch, Jan $u Department of Surgery and Transplantation, University Hospital RWTH Aachen, Aachen, Germany.
700    1_
$a Amygdalos, Iakovos $u Department of Surgery and Transplantation, University Hospital RWTH Aachen, Aachen, Germany.
700    1_
$a Cramer, Thorsten $u Department of Surgery and Transplantation, University Hospital RWTH Aachen, Aachen, Germany.
700    1_
$a Rogiers, Xavier, $u Department of Solid Organ Transplantation, Ghent University Hospital and Medical School, Ghent, Belgium. $d 1956-2019 $7 xx0271824
700    1_
$a Popescu, Irinel $u Department of General Surgery and Liver transplantation, Fundeni Clinical Institute, Bucharest, Romania.
700    1_
$a Botea, Florin $u Department of General Surgery and Liver transplantation, Fundeni Clinical Institute, Bucharest, Romania.
700    1_
$a Froněk, Jiří $u Department of Transplantation Surgery, Institute for Clinical and Experimental Medicine, Prague, Czech Republic.
700    1_
$a Kroy, Daniela $u Department of Medicine III, University Hospital RWTH Aachen, Aachen, Germany.
700    1_
$a Koch, Alexander $u Department of Medicine III, University Hospital RWTH Aachen, Aachen, Germany.
700    1_
$a Tacke, Frank $u Department of Medicine III, University Hospital RWTH Aachen, Aachen, Germany.
700    1_
$a Trautwein, Christian $u Department of Medicine III, University Hospital RWTH Aachen, Aachen, Germany.
700    1_
$a Tolba, Rene H $u Institute for Laboratory Animal Science and Experimental Surgery, University Hospital RWTH Aachen, Aachen, Germany.
700    1_
$a Hein, Marc $u Department of Anesthesiology, University Hospital RWTH Aachen, Aachen, Germany.
700    1_
$a Koek, Ger H $u Section of Gastroenterology and Hepatology, Department of Internal Medicine, Maastricht University Medical Centre (MUMC), Maastricht, The Netherlands.
700    1_
$a Dejong, Cornelis H C $u Department of Surgery and Transplantation, University Hospital RWTH Aachen, Aachen, Germany. Department of Surgery, Maastricht University Medical Centre (MUMC), Maastricht, Netherlands.
700    1_
$a Neumann, Ulf Peter $u Department of Surgery and Transplantation, University Hospital RWTH Aachen, Aachen, Germany. Department of Surgery, Maastricht University Medical Centre (MUMC), Maastricht, Netherlands.
700    1_
$a Lurje, Georg $u Department of Surgery and Transplantation, University Hospital RWTH Aachen, Aachen, Germany.
773    0_
$w MED00184484 $t BMJ open $x 2044-6055 $g Roč. 7, č. 10 (2017), s. e017558
856    41
$u https://pubmed.ncbi.nlm.nih.gov/29018070 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20180709 $b ABA008
991    __
$a 20220407135449 $b ABA008
999    __
$a ok $b bmc $g 1316712 $s 1021502
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2017 $b 7 $c 10 $d e017558 $e 20171010 $i 2044-6055 $m BMJ open $n BMJ Open $x MED00184484
LZP    __
$a Pubmed-20180709

Najít záznam

Citační ukazatele

Možnosti archivace